Cause-specific mortality in long-term survivors of retinoblastoma

Journal of the National Cancer Institute

Volumn 101, Issue 8, 2009, Pages 581-591

  Yu, Chu Ling ^a   Tucker, Margaret A ^a   Abramson, David H ^b   Furukawa, Kyoji ^c   Seddon, Johanna M ^d   Stovall, Marilyn ^e   Fraumeni, Joseph F ^a   Kleinerman, Ruth A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^d TUFTS MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CANCER SURVIVOR; CHILD; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINOBLASTOMA; SCHOOL CHILD; SECOND CANCER; UNITED STATES; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETICS; HEALTH SURVEY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; POISSON DISTRIBUTION; RADIOTHERAPY; RETINA TUMOR; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; STATISTICS; SURVIVAL RATE; SURVIVOR;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, SECOND PRIMARY; POISSON DISTRIBUTION; POPULATION SURVEILLANCE; RADIOTHERAPY; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; SURVIVORS; UNITED STATES;

EID: 64749089013     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp046     Document Type: Article

References (31)

1. Classon M, Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer. 2002;2(12):910-917.
2. Goodrich DW. The retinoblastoma tumor-suppressor gene, the exception that proves the rule. Oncogene. 2006;25(38):5233-5243.
3. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57-70.
4. Weinberg RA. The Biology of Cancer. New York, NY:Garland Science;2007.
5. Acquaviva A, Ciccolallo L, Rondelli R, et al. Mortality from second tumour among long-term survivors of retinoblastoma:a retrospective analysis of the Italian retinoblastoma registry. Oncogene. 2006;25(38):5350-5357.
6. Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993;85(14):1121-1128.
7. Fletcher O, Easton D, Anderson K, et al. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst. 2004;96(5):357-363.
8. Kleinerman RA, Tarone RE, Abramson DH, et al. Hereditary retinoblas-toma and risk of lung cancer. J Natl Cancer Inst. 2000;92(24):2037-2039.
9. Kleinerman RA, Tucker MA, Tarone RE, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma:an extended follow-up. J Clin Oncol. 2005;23(10):2272-2279.
10. Marees T, Moll AC, Imhof SM, et al. Risk of second malignancies in survivors of retinoblastoma:more than 40 years of follow-up. J Natl Cancer Inst. 2008;100(24):1771-1779.
11. Wong FL, Boice JD Jr, Abramson DH, et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA. 1997;278(15):1262-1267.
12. Abramson DH, Melson MR, Dunkel IJ, Frank CM. Third(fourth and fi fth) nonocular tumors in survivors of retinoblastoma. Ophthalmology. 2001;108(10):1868-1876.
13. Kim JW, Abramson DH, Dunkel IJ. Current management strategies for intraocular retinoblastoma. Drugs. 2007;67(15):2173-2185.
14. Abramson DH, Frank CM. Second nonocular tumors in survivors of bilateral retinoblastoma:a possible age effect on radiation-related risk. Ophthalmology. 1998;105(4):573-579;discussion 579-580.
15. Moll AC, Imhof SM, Schouten-Van Meeteren AY, et al. Second primary tumors in hereditary retinoblastoma:a register-based study, 1945-1997:is there an age effect on radiation-related risk? Ophthalmology. 2001;108(6):1109-1114.
16. Hurwitz RL, Shields CL, Shields JA, et al. Retinoblastoma. In:Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 4th ed. Philadelphia, PA:Lippincott Williams & Wilkins;2002:825-846.
17. US Department of Health, Education, and Welfare, Public Health Service, National Center for Health Statistics. Eighth Revision of International Classification of Diseases, Adapted for use in the United States. Washington, DC:US Government Printing Office, 1968.
18. Monson RR. Analysis of relative survival and proportional mortality. Comput Biomed Res. 1974;7(4):325-332.
19. Breslow NE, Day NE. Statistical Methods in Cancer Research:Volume II-The Design and Analysis of Cohort studies. Lyon, France: International Agency for Research on Cancer; 1987.
20. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks:new representations of old estimators. Stat Med. 1999;18(6):695-706.
21. Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Statist. 1988;16(3):1141-1154.
22. Boice JD Jr. Ionizing radiation. In:Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. 3rd ed. New York, NY:Oxford University Press; 2006:259-293.
23. Mertens AC, Liu Q, Neglia JP, et al. Cause-specifi c late mortality among 5-year survivors of childhood cancer:the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2008;100(19):1368-1379.
24. Shields CL, Shields JA. Diagnosis and management of retinoblastoma. Cancer Control. 2004;11(5):317-327.
25. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13:solid cancer and noncan-cer disease mortality:1950-1997. Radiat Res. 2003;160(4):381-407.
26. Bowers DC, Liu Y, Leisenring W, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors:a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24(33):5277-5282.
27. Bowers DC, McNeil DE, Liu Y, et al. Stroke as a late treatment effect of Hodgkin ' s disease:a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2005;23(27):6508-6515.
28. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol. 1993;11(7):1208-1215.
29. Heikens J, Ubbink MC, van der Pal HP, et al. Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease. Cancer. 2000;88(9):2116-2121.
30. Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in fi ve-year survivors of childhood and adolescent cancer:the Childhood Cancer Survivor Study. J Clin Oncol. 2001;19(13):3163-3172.
31. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics - 2009 update:a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):e21-e181.